Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 468Neoplasms 332Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 235Lung Neoplasms 200Prostatic Neoplasms 182Carcinoma, Hepatocellular 175Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 115Uterine Cervical Neoplasms 111Rectal Neoplasms 103Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 80Ovarian Neoplasms 78Neoplasm Metastasis 77Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 64Endometrial Neoplasms 61Small Cell Lung Carcinoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 54Hematologic Neoplasms 54Disease 54Glioma 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Hepatocellular Carcinoma Resectable × Clear all
NCT07363356 2026-01-23

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Eastern Hepatobiliary Surgery Hospital

Phase 2 Not yet recruiting
56 enrolled
Gastrointestinal

Hepatocellular Carcinoma Resectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡